shenzhen salubris pharmaceuticals co., ltd.-j9九游会真人游戏第一
shenzhen salubris pharmaceuticals co., ltd.-j9九游会真人游戏第一
join us
九游会j9·(中国)真人游戏第一品牌
home page
about us
profile
affiliates/subsidiaries
development history
quality management
contact us
legal statement
adverse reaction report
science and technology
r&d platform
r&d pipeline
therapeutic field
international business
apis
finished products
medical device
download product list
contact
news center
news & trends
public information
news & trends
11
2023-01
clinical trial approved! good news for sal0133 tablets
11
2023-01
sal008 injection for the treatment of advanced solid tumors approved for clinical trial
11
2023-01
the application for a clinical trial of sal0133 tablets for the treatment of mild/common covid-19 in adults was accepted
11
2023-01
new clinical progress of sal003 for the treatment of hypercholesterolemia and mixed hyperlipidemia
11
2023-01
two alliances for biomedicine and high-end medical devices established
24
2022-11
ind acceptance by nmpa for sal0119 tablets for the treatment of active ankylosing spondylitis and moderate-to-severe active rheumatoid arthritis
目前在第
2
页,
共有
9
页,
共有
49
条记录
第一页
上一页
1
2
3
4
5
下一页
最后一页
跳转到
页
网站地图